Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

BriaCell Therapeutics Corp. (BCTXF) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/25/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Director of Public Relations"
08/21/2023 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits  Interac...
Docs: "Press release issued August 18, 2023"
07/26/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
06/30/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/17/2023 8-K Quarterly results
03/29/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/20/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
02/23/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Director of Public Relations"
02/10/2023 8-K Quarterly results
01/24/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Director of Public Relations"
01/23/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Director of Public Relations"
01/18/2023 8-K Quarterly results
01/17/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
01/10/2023 8-K Quarterly results
01/05/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
12/14/2022 10-Q Quarterly Report for the period ended October 31, 2022
12/08/2022 8-K Quarterly results
11/30/2022 8-K Quarterly results
11/10/2022 8-K Quarterly results
10/27/2022 10-K Annual Report for the period ended July 31, 2022
10/27/2022 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ...
Docs: "NOTICE TO READER",
"NOTICE TO READER",
"NOTICE TO READER",
"NOTICE TO READER",
"NOTICE TO READER",
"NOTICE TO READER"
10/21/2022 8-K Quarterly results
09/14/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Caris Life Sciences Media Contact:"
08/04/2022 8-K Quarterly results
08/01/2022 SC 13G Lynwood Capital Management Inc. reports a 5.6% stake in BriaCell Therapeutics Corp.
07/18/2022 6-K Quarterly results
07/05/2022 6-K Quarterly results
06/29/2022 6-K Quarterly results
06/24/2022 6-K Quarterly results
06/13/2022 6-K Quarterly results
05/18/2022 6-K Quarterly results
04/25/2022 SC 13G Southwest Private Capital Inc. reports a 5.1% stake in § 240.13d-2. BriaCell Therapeutics Corp.
04/13/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2022 Commission File Number: 001-40101 BRIACELL THERAPEUTICS CORP. Suite 300 – 235 15 th Street West Vancouver, BC V7T 2X1 Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐ Form 40-F ☒ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: ☐ Exhibit Number Description 99.1 Press Release dated April 13...",
"Director of Public Relations"
04/12/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2022 Commission File Number: 001-40101 BRIACELL THERAPEUTICS CORP. Suite 300 – 235 15 th Street West Vancouver, BC V7T 2X1 Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐ Form 40-F ☒ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: ☐ Exhibit Number Description 99.1 Press Release dated April 12...",
"Director of Public Relations"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy